Comments
Loading...

Lumos Pharma

LUMONASDAQ
Logo brought to you by Benzinga Data
$3.70
-0.22-5.61%
Last update: Sep 5, 7:43 PM
15 minutes delayed

Lumos Pharma (NASDAQ:LUMO) Stock, Earnings Estimates, EPS, And Revenue

Lumos Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 5
EPS Estimate
$-0.690
Quarterly Revenue Estimate
$170K
Annual Revenue
(as of Jun 30)
$1.5M

Analyze the earnings history of Lumos Pharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

Lumos Pharma (LUMO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-01$-0.93$-1.2425.0 %
Mar 20242024-05-14$-1.29$-1.18-9.32 %
Dec 20232024-03-07$-1.17$-1.15-1.74 %
Sep 20232023-11-07$-1.04$-1.159.57 %

Lumos Pharma (LUMO) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-01$488.00K$330.00K47.9 %
Mar 20242024-05-14$165.00K$300.00K-45.0 %
Sep 20232023-11-07$7.00K$320.00K-97.8 %
Jun 20232023-08-09$527.00K$410.00K28.5 %

FAQ

Q

When is Lumos Pharma (NASDAQ:LUMO) reporting earnings?

A

Lumos Pharma (LUMO) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Lumos Pharma (NASDAQ:LUMO)?

A

The Actual EPS was $-0.93, which beat the estimate of $-1.24.

Q

What were Lumos Pharma’s (NASDAQ:LUMO) revenues?

A

The Actual Revenue was $488K, which beat the estimate of $330K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch